• In the UK, a private clinic LVL Health authorised an initial study of pure cannabis for those suffering from chronic pain. The trial ’Canpain,’ will begin with 100 patients with plans to scale to a bigger experiment of 5,000 adults between ages 18 to 85, and will run for the next three years. This study will develop data to allow deeper analysis of the effects of cannabis on patients. Cannabis prescriptions for patients are a last resort for the NHS due to the cost of issuing medication and the relative inefficient evidence to support cannabis use in medicine. Simultaneously, some patients have stressed the benefits of cannabis in assisting with anxiety, pain and nausea and a need for better accessibility. This trial is a push in the right direction to emphasise the value of cannabis in medicine and reduce the data gap, allowing medical experts and policy makers to make better informed decision.

​

• Croatia have recently opened their first cannabis museum, 400m2 in their capital, Zagreb across a police station, with aims to educate the public about the plant. The museum offers cultural exhibits featuring high tunes and stoner movies as well as a wholesome approach to the history of cannabis consumption. Admission is free for individuals working in health and agriculture sectors responsible for regulating cannabis- the admission ticket can also be rolled and smoked so you can worry less about leaving your papers packs at home.

​

• California is a leading state in marijuana legislation, and Hall of Flowers is an event set to amplify California's hub of cannabis. Hall of Flowers is delivering an experience that elevates the cannabis industry to “a new level of cultural significance” on May 4-5, 2022, in Palm springs. Hall of Flowers is a licensed, industry only highly curated B2B trade show. The first day is open to cannabis brands, businesses and retail buyers to network and sample their premium products to some of the largest dispensaries and smaller dispensary owners. Day 2 comprises a similar set-up but this time opens its doors to the broader industry with ticket prices standing at $750.

​

• Malawi's exit strategy for tobacco cultivation is looking like it may be cannabis. Economic survival is critical for Malawi and expressing interest in cannabis cultivation can be a big game changer for Africa as a whole. In South Africa, officials have begun a plan for a so-called “cannabis hub” the focus will be medical cannabis cultivation and phytoremediation. This move will be influential on surrounding regions. China has been one of the main investors in the African continent for regenerations and roadwork over the past century but as cannabis reform is off the political agenda for China and remain strict on punishemnt for possession we doubt they will show much interest in the emerging global market but on the other hand the West is all eyes and ears. The high price of product in the regulated market across some areas of Europe discourage consumers from purchasing legal product but a strong African cannabis market will contrubite to bringing this cost down similarly with tobacco. Cannabis reform is spreading like wild fire across the globe and is a force not to be played with.